Liang, T., Xie, X., Wu, L., Li, L., Yang, L., Gao, H., Deng, Z., Zhang, X., Chen, X., Zhang, J., Ding, Y., & Wu, Q
One critical consideration when purchasing medication abroad: you may not have easy access to your prescribing physician if something goes wrong
The Takeaway While both Novo and Lilly have multi-year regulatory head-starts and are now rapidly becoming part of the zeitgeist around treating obesity, Regenerons angle of addressing muscle loss could help set it apart from other GLP-1 hopefuls and even incumbents by leading to improved long-term outcomes.
The multiple pharmacological treatment options will enhance clinicians ability to identify effective personalised regimens by trying a second medication or combining medications with synergistic or complimentary actions or even escalating treatment to bariatric surgery based on patient preference and underlying comorbidities [7]
Semaglutide GLP-1 is typically administered once a week, either via subcutaneous injection or a pre-filled pen